Prof. Dr. İlhan Tarkun
Endocrinology and Metabolic Diseases. The branch of medicine that looks after diseases of the glands that make hormones, such as the thyroid, and of how the body turns food into energy.
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which topics does this doctor work on?
Medical areas of interest the doctor lists on their own profile on the institution’s website. Source: anadolusaglik.org.
- Endokrinoloji ve metabolizma hastalıkları
- Diyabet Tiroit hastalıkları
- Hipofiz hastalıkları
- Obezite
- Adrenal bez hastalıkları
CV
Education and experience
2018 yılında geldiği Anadolu Sağlık Merkezi’nde Endokrinoloji Uzmanı olarak görevini sürdürüyor.
Experience
- ExperienceKocaeli Üniversitesianadolusaglik.org
- ExperienceAnadolu Sağlık Merkezianadolusaglik.org
Education
- EducationMarmara Üniversitesi Tıp Fakültesi, 1989.anadolusaglik.org
- EducationHaydarpaşa Numune Hastanesi, İç Hastalıkları Uzmanlığı, 1996.anadolusaglik.org
- EducationKocaeli Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı Endokrinoloji ve Metabolizma Hastalıkları Bilim Dalı, Yan Dal Uzmanlığı, 2001.anadolusaglik.org
- EducationKocaeli Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Endokrinoloji ve Metabolizma Hastalıkları Bilim Dalı, Doçent, 2006.anadolusaglik.org
- EducationKocaeli Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Endokrinoloji ve Metabolizma Hastalıkları Bilim Dalı, Profesör, 2011-2018.anadolusaglik.org
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyEndocrinology and Metabolic Diseasesanadolusaglik.orgFrom source
- InstitutionAnadolu Sağlık Merkezi Hastanesianadolusaglik.orgFrom source
- Publications33 publicationsanadolusaglik.org profile pageFrom source
- Last synchronised11 November 2026 22:59https://www.anadolusaglik.org/doktor/ilhan-tarkunanadolusaglik.org
Scientific work
Publications
-
Selek A., Çetinarslan B., Cantürk Z., Tarkun İ., Akyay OZ., Çabuk B., Ceylan S., The Utility of Preoperative ACTH/Cortisol Ratio for the Diagnosis and Prognosis of Cushing's Disease, J. Neurosci Rural Pract. 2018 Jan-Mar; 9(1): 106-11. doi: 0.4103/jnrp.jnrp_308_17.
Source: anadolusaglik.org profile page
-
Gürkan E., Tarkun İ.*, Şahin T., Effect of Exenatide on Aortic Stiffness and Blood Pressure Parameters. Turkish Journal of Endoc. Metab. 2017 21(4); 97-103.
Source: anadolusaglik.org profile page
-
İ. Tarkun, S. Dumanlı Attitudes, wishes, and needs of diabetes patients and their relatives: Turkish data from the DAWN2 study. Turkish J. Med Sci 2017 Apr 18;47(2):447-45.
Source: anadolusaglik.org profile page
-
Karci AC, Canturk Z, Tarkun İ., Çetinarslan B., Matrix metalloproteinase 2 (MMP-2) levels are increased in active acromegaly patients.
Source: anadolusaglik.org profile page
-
Selek A, Çetinarslan B, Tarkun İ, Cantürk Z, Üstüner B, Akyay Z., Thyroid autoimmunity: is really associated with papillary thyroid carcinoma? Eur Arch Otorhinolaryngol. 2017 Mar; 274(3): 1677-1681.
Source: anadolusaglik.org profile page
-
Selek A., Barış S., Çetinarslan B., Cantürk Z., Tarkun İ., Akyay Z., New-Onset Sarcoidosis After Remission of Cushing's Syndrome. Turk Thorac J. 2016 Jan;17(1):35-37.
Source: anadolusaglik.org profile page
-
Selek A., Çetinarslan B., Kıvrakoğlu E., Karadağ DT., Tarkun İ., Cantürk Z., Akyay OZ., Histologic outcome of thyroid nodules with repeated diagnosis of atypia in thyroid fine-needle aspiration biopsy. Future Oncol. 2016 Mar; 12(6): 801-5.
Source: anadolusaglik.org profile page
-
Selek A., Çetinarslan B., Gürbüz Y., Tarkun İ., Cantürk Z., Çabuk B. Aromatase enzyme expression in acromegaly and its possible relationship with disease prognosis. Endocrine 2015 May; 49(1):250-7.
Source: anadolusaglik.org profile page
-
Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J., Josse R., Kaufman KD, Koglin J., Korn S., Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S., Van de Werf F., Peterson ED, Holman RR; TECOS Study Group. Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. N. Engl J. Med. 2015 Jul 16;373(3):232-42.
Source: anadolusaglik.org profile page
-
Gürkan E., Tarkun İ., Şahin T., Çetinarslan B., Cantürk Z., Evaluation of exenatide versus insulin glargine for the impact on endothelial functions and cardiovascular risk markers. Diabetes Res Clin Pract. 2014 Dec;106(3): 567-75.
Source: anadolusaglik.org profile page